Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC
Phase 2
Recruiting
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 35
- Registration Number
- NCT06467617
- Locations
- 🇨🇳
Beijing Chest Hospital, Beijing, Beijing, China
PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
Phase 2
Not yet recruiting
- Conditions
- Limited-stage Small-cell Lung Cancer
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-04-19
- Target Recruit Count
- 60
- Registration Number
- NCT06375109
© Copyright 2025. All Rights Reserved by MedPath